Patient Motivation, Rewards Program Boosts Medication Compliance
Clinical trials struggling with participant compliance issues could find a model in an innovative patient incentive program run by Boehringer Ingelheim (BI) that rewards chronic obstructive pulmonary disease (COPD) patients for sticking to their treatment regimen.
An observational study of BI’s RespiPoints program — a digital platform that sends participants daily medication reminders, educational content and behavior change activities — showed a 44 percent improvement in drug adherence among participating patients compared to those not in the program.
The program, developed by consumer health motivation company HealthPrize, uses gamification to educate patients with COPD and encourage them to take their medication.
Patients using the platform earn points toward an electronic gift card. According to the BI study, program participants were 2.5 times more likely to adhere to their treatment, at 47 percent lower risk of discontinuing their index prescription, had significantly more prescription fills and a significantly shorter time gap between fills.